These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V, Haro JM, Alonso J. J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721 [Abstract] [Full Text] [Related]
16. [The influence of alprazolam on the symptoms of anxiety and depression]. Małyszczak K, Kiejna A. Psychiatr Pol; 1997 Sep; 31(6):745-52. PubMed ID: 9515306 [Abstract] [Full Text] [Related]
17. The impact of comorbidity on the treatment of panic disorder. Lecrubier Y. J Clin Psychiatry; 1998 Sep; 59 Suppl 8():11-4; discussion 15-6. PubMed ID: 9707157 [Abstract] [Full Text] [Related]
19. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. Jonas JM, Cohon MS. J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888 [Abstract] [Full Text] [Related]
20. The psychopharmacology of social phobia and comorbid disorders. Rosenbaum JF, Pollock RA. Bull Menninger Clin; 1994 Oct; 58(2 Suppl A):A67-83. PubMed ID: 7913851 [Abstract] [Full Text] [Related] Page: [Next] [New Search]